Morning Overview on MSN
A new non-stimulant ADHD medication just won FDA approval
Attention-deficit/hyperactivity disorder has long been treated mainly with stimulants, and the handful of non-stimulant ...
Welltica+ on MSN
Experts call for changes to ADHD treatment after new research
Experts are calling for changes to ADHD care as new research raises questions about medication safety.
The US FDA has accepted for priority review Otsuka Pharmaceutical’s NDA submitted for centanafadine, an investigational, once-daily extended-release capsule for ADHD treatment.
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of ...
Cognitive behavioral therapy (CBT) is a vetted, evidence-based psychosocial treatment for adult ADHD. Such evidence-based status is established chiefly by way of randomized controlled clinical trials.
ADHD symptoms can sometimes overshadow autism traits, making them harder to recognize. Treatment may change that balance.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results